ANX009

· Annexon, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANX009, covering 2024-08-22 to 2024-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ANX009 in Adult Participants With Lupus Nephritis [Phase 1]